Investments
30Portfolio Exits
4
Want to inform investors similar to Qingsong Capital about your company?
Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.
Qingsong Capital Investments
30 Investments
Qingsong Capital has made 30 investments. Their latest investment was in Bioengine as part of their Series C on May 5, 2023.
Qingsong Capital Investments Activity
Date | Round | Company | Amount | New? | Co-Investors | Sources |
|---|---|---|---|---|---|---|
5/15/2023 | Series C | Bioengine | $43M | No | 2 | |
3/9/2023 | Seed VC - II | Olipharma | Yes | 1 | ||
2/20/2023 | Series A | Bio-Link | No | |||
9/2/2022 | Series A | |||||
8/5/2022 | Series C |
Date | 5/15/2023 | 3/9/2023 | 2/20/2023 | 9/2/2022 | 8/5/2022 |
|---|---|---|---|---|---|
Round | Series C | Seed VC - II | Series A | Series A | Series C |
Company | Bioengine | Olipharma | Bio-Link | ||
Amount | $43M | ||||
New? | No | Yes | No | ||
Co-Investors | |||||
Sources | 2 | 1 |
Qingsong Capital Portfolio Exits
4 Portfolio Exits
Qingsong Capital has 4 portfolio exits. Their latest portfolio exit was United Imaging Healthcare on August 22, 2022.
Date | Exit | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Acquirer | Sources |
|---|---|---|---|---|---|
8/22/2022 | IPO | Public | 2 | ||
Date | 8/22/2022 | |||
|---|---|---|---|---|
Exit | IPO | |||
Companies | ||||
Valuation | ||||
Acquirer | Public | |||
Sources | 2 |
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.